Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Invest-NL
AmsterdamSeries A–Growth
23 people
Agent Capital
WalthamSeed–Late Stage
24 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
venBio Partners
San FranciscoSeed–Series C
10 people
Peregrine Ventures
Or YehudaSeed–Late Stage$500K – $3M
14 people
Fortune Venture Capital
ShenzhenSeed–Series C
11 people
Claret Capital Partners
LondonSeries A–Late Stage
27 people
Neotribe Ventures
Menlo ParkPre-Seed–Growth$250K – $2M
12 people
Corewell Health Ventures
Grand RapidsSeries B–Late Stage
5 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
8 people
McKesson Ventures
San FranciscoSeed–Growth
17 people
IDG Capital
Hong KongPre-Seed–Late Stage$1M – $100M
8 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Growth
11 people
Georgian
Toronto, OntarioSeries C–Growth$25M – $100M
18 people
Sampac Tech Fund
Palo AltoSeed–Late Stage
31 people
Domain Associates
PrincetonSeed–Growth$200K – $15M
11 people
Dentsu Ventures
TokyoSeed–Late Stage
12 people
UKSE
SheffieldSeries A–Late Stage
34 people
Lilly Asia Ventures
Hong KongPre-Seed–Series C
3 people
Remgro / Invenfin ecosystem
StellenboschSeed–Growth
21 people
Windham Capital Partners
New YorkSeries A–Growth$1M – $5M
17 people
TCG Crossover
Palo AltoSeed–Late Stage
25 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
12 people
PortfoLion Capital Partners
BudapestSeed–Growth$540K – $32.4M
31 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.


































































































